{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:26:42Z","timestamp":1649179602397},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.trsl.2009.10.006","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T10:19:00Z","timestamp":1259749140000},"page":"120-122","source":"Crossref","is-referenced-by-count":2,"title":["Is there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis?"],"prefix":"10.1016","volume":"155","author":[{"given":"Marina G.","family":"Silveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2009.10.006_bib1","unstructured":"Askari F, Innis D, Dick R, et\u00a0al. Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double blind trial. Trans Res; in press."},{"key":"10.1016\/j.trsl.2009.10.006_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2009.10.006_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4065\/73.2.179","article-title":"Ludwig symposium on biliary disorders\u2014part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"73","author":"Scheuer","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trsl.2009.10.006_bib4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.trsl.2009.10.006_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2009.10.006_bib7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2009.10.006_bib8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2009.10.006_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.trsl.2009.10.006_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2009.10.006_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2009.10.006_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2009.10.006_bib14","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2009.10.006_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","article-title":"Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease","volume":"63","author":"Brewer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.trsl.2009.10.006_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/153537020422900820","article-title":"Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice","volume":"229","author":"Askari","year":"2004","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.trsl.2009.10.006_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.107.131227","article-title":"Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis","volume":"325","author":"Song","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2009.10.006_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2009.10.006_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.510300415","article-title":"Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?","volume":"30","author":"Krzeski","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.510290140","article-title":"Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis","volume":"29","author":"Bonnand","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib22","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1002\/hep.21046","article-title":"Noninvasive measures of liver fibrosis","volume":"43","author":"Rockey","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840050613","article-title":"A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis","volume":"5","author":"Bodenheimer","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2009.10.006_bib24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2009.10.006_bib25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2009.10.006_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.trsl.2009.10.006_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2009.10.006_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0676.1983.tb00887.x","article-title":"Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis","volume":"3","author":"Taal","year":"1983","journal-title":"Liver"},{"key":"10.1016\/j.trsl.2009.10.006_bib29","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.03164.x","article-title":"Systematic review and meta-analysis: D-Penicillamine vs. placebo\/no intervention in patients with primary biliary cirrhosis\u2014Cochrane Hepato-Biliary Group","volume":"24","author":"Gong","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T05:19:46Z","timestamp":1558675186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524409003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1931524409003235"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2009.10.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}